Pfizer appoints former J&J executive to lead obesity drug development
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
Pfizer names James List Chief Internal Medicine Officer
Pfizer (PFE) announced that James List has joined the company as Chief Internal Medicine Officer. List will oversee Pfizer’s Internal Medicine ...
Pfizer appoints former J&J executive to lead development of obesity medicines
Pfizer on Thursday named James List as the head of the drugmaker's Internal Medicine portfolio, where he will oversee the ...
Zacks Investment Research on MSN4h
Pfizer (PFE) Down 1.9% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for Pfizer (PFE). Shares have lost about 1.9% in that time frame, outperforming the S&P 500. Will the recent negative trend continue leading up to ...
Here's Why Moderna Stock Soared 16% on Wednesday
The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.
Tuoi Tre News18h
Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
The Patent Trial and Appeal Board agreed with Pfizer and its German partner that Moderna's patents were invalid based on "prior art" that disclosed the inventions before Moderna patented them. The ...